Migraine Medication Market

Industry Size, Emerging Trends, Regions, Growth Insights, Opportunities, and Forecast By 2033

Migraine Medication Market by Treatment (Acute / Abortive Treatment, and Preventive/ Prophylactic Treatment), by Therapeutics (Triptans, Acetylcholine Inhibitors/ Neurotoxins, Ergot Alkaloids, Ditans), by Route of Administration, by End-User, and by Region – Global Share and Forecast to 2033

Region: Global | Format: Word, PPT, Excel | Report Status: Ongoing

According to the Market Statsville Group (MSG), the Global Migraine Medication Market size is expected to grow from USD 5,742.4 million in 2023 to USD 12,175.1 million by 2033, at a CAGR of 8.4% from 2023 to 2033. 
Migraines are debilitating neurological disorders characterized by severe, throbbing headaches that are frequently accompanied by various other symptoms such as light and sound sensitivity, nausea, and vomiting. These medications are designed to provide relief by targeting various mechanisms involved in the onset and progression of migraines. Acute treatments are administered at the onset of a migraine attack to provide immediate relief from pain and other symptoms. These medications include over-the-counter pain relievers such as ibuprofen and prescription medications such as triptans, which constrict blood vessels and reduce inflammation in the brain. Preventive treatments, on the other hand, are administered regularly in order to reduce the frequency and severity of migraine attacks. Beta-blockers, antidepressants, anticonvulsants, and CGRP (calcitonin gene-related peptide) inhibitors are instances of these medications.
Migraines are very common and are becoming more common. As people become more aware of and understand migraines, more people seek medical attention, increasing demand for medications. With the global prevalence of migraines, there has been an increase in healthcare consultations, prescriptions, and over-the-counter purchases of migraine-specific drugs. Also, advances in medical research and technology have resulted in the development of novel migraine medications. CGRP inhibitors, for instance, have received attention for their efficacy in providing relief and reducing the frequency of migraine attacks. This influx of novel treatments has driven the market demand even higher. 

Migraine Medication Market Segmental Analysis, 2023-2033

Based on end-users, the market is divided into hospital pharmacies, online pharmacies, and retail pharmacies. The hospital pharmacies segment accounted for the largest market share in 2023. Hospital pharmacies attracts wide range of patients, including those suffering from severe and incapacitating migraines. These pharmacies are strategically placed within healthcare facilities, allowing them to dispense acute and preventive migraine medications to patients seeking immediate relief or long-term management. The presence of specialized healthcare professionals in hospitals also ensures accurate prescription dispensing and patient education about proper medication usage.
Based on the regions, the global migraine medication market has been segmented across Europe, North America, the Middle East & Africa, Asia-Pacific, and South America. North America accounted for the largest market share in 2023. The growing prevalence of migraines in the North America is the major driver contributing to the market growth. As people become more aware of and understand migraines, more people seek medical help, creating a greater demand for effective migraine medications. Modern life's changing lifestyle patterns and stressors have contributed to the rise in migraine incidence. Migraines can be triggered or exacerbated by irregular sleep patterns, high-stress environments, and dietary habits. As these lifestyle factors become more common, the need for dependable and fast-acting migraine medications has risen.

Migraine Medication Market Key Players, 2023

The Major key players in the global migraine medication market are: 

  • GSK
  • Teva
  • Pfizer
  • Amgen
  • Viatris
  • Allergan
  • Grunenthal
  • Eli Lilly
  • Johnson & Johnson
  • Bayer
  • Haleon
  • Tongde Pharmacy
  • Huazhong Pharmaceutical
  • Weisen Pharmaceutical
  • DIAO GROUP
  • Jiheng Pharmaceutical
  • Dirui Pharmaceutical

Report Scope of the Global Migraine Medication Market 

This market research study categorizes the migraine medication market-based on treatment, route of administration, therapeutic, and end-user area at the regional and global levels.

By Type Outlook (Sales, USD Million, 2019-2033)

  • Acute / Abortive Treatment
  • Preventive/ Prophylactic Treatment 

By Therapeutics Outlook (Sales, USD Million, 2019-2033)

  • Triptans
  • Acetylcholine Inhibitors/ Neurotoxins
  • Ergot Alkaloids
  • NSAIDs
  • Ditans
  • CGRP Small Molecule Antagonists
  • CGRP Monoclonal Antibodies
  • Others

By Route of Administration Outlook (Sales, USD Million, 2019-2033)

  • Oral
  • Injectables
  • Others

By End-User Outlook (Sales, USD Million, 2019-2033)

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies

By Region Outlook (Sales, USD Million, 2019-2033)

  • North America 
    • US
    • Canada
    • Mexico
  • Europe 
    • Germany
    • Italy
    • France
    • UK
    • Spain
    • Poland
    • Russia
    • The Netherlands
    • Norway
    • Czech Republic
    • Rest of Europe
  • Asia Pacific 
    • China
    • Japan
    • India
    • South Korea
    • Indonesia
    • Malaysia
    • Thailand
    • Singapore
    • Australia & New Zealand
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • The Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Northern Africa
    • Rest of MEA

Frequently Asked Questions

  • Key Issues Addressed
  • What is the market size and growth rate for different segmentations at a global, regional, & country level?
  • What is the customer buying behavior, key takeaways, and Porter's 5 forces of the market?
  • What are the key opportunities and trends for manufacturers involved in the supply chain?
  • What are the fundamental dynamics (drivers, restraints, opportunities, and challenges) of the market?
  • What and how regulations, schemes, patents, and policies are impacting the growth of the market?
  • How will existing companies adapt to the new change in technology?
  • The market player positioning, top winning strategies by years, company product developments, and launches will be?
  • How has COVID-19 impacted the demand and sales of in the market? Also, the expected BPS drop or rise count of the market and market predicted recovery period.
  • Who are the leading companies operating in the market? Also, who are the prominent startups that disrupt the market in coming years?
  • PUBLISHED ON: MARCH, 2024
  • BASE YEAR: 2023
  • FORECAST PERIOD: 2024-2033
  • STUDY PERIOD: 2019 - 2033
  • COMPANIES COVERED: 15
  • COUNTRIES COVERED: 24
  • NO OF PAGES: 238

Want to Review Complete Market Research Report

 
save 20%
$2450 $1950
 
save 25%
$4450 $3338
 
save 30%
$5850 $4095
 
save 35%
$8150 $5298

Budget constraints? Get in touch with us for special pricing

Request for Special Pricing

Customize this Report

  • Buy specific region or segment sections of this report
  • Buy specific region/country level reports
  • Request for Pricing Analysis, Market Dynamics, Recommendation & Conclusion
  • Companies Profiles based on Target Requirement
  • Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
  • Why Choose Market Statsville Group?
  • CXO’s Perspective
  • Real-Time Market AttractivenessIndex
  • Investment Pockets
  • Market Player Positioning
  • Competitive Heatmap
  • Parent &Peer Market Analysis
  • Primary Survey Analysis & Transcripts
  • Premium insights from industry experts
  • Robust Research Methodology
  • Market Trends & Opportunities
  • Market Growth Dynamics
  • Value/Supply Chain Analysis
  • Pre-&-Post Covid Market Scenario
  • Latest Technological Developments
  • Comprehensive Reports
  • 3-Rounds Quality Checks with Complete Assurance
  • Unlimited Post-Sales Support
  • Regular Report Updates
Didn't Get What you are looking for. Share your requirements here
Request for Customization

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. I Accept